Skip to main content

Our Science Impacts Lives

Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.

482 million

patients living with conditions that our pipeline aims to treat, from cancer and Alzheimer’s disease to chronic
immune-mediated conditions

Therapeutic Focus Areas

Researching Areas of Unmet Medical Need

We’re constantly finding new ways to address patients’ most serious health issues. We concentrate our efforts on a core set of therapeutic areas—ones where we’ve proven our expertise, and where we feel we can have an even greater impact on disease and how it is managed.

Explore

Where We Operate

Eight state-of-the-art R&D centres: 

Lake County, Illinois, USA
Redwood City, California, USA
Sunnyvale, California, USA (Pharmacyclics)
South San Francisco, California, USA
Cambridge, Massachusetts, USA
Worcester, Massachusetts, USA
Ludwigshafen, Germany
Tokyo, Japan

Technologies and Platforms

Bringing Better Solutions to Patients

By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.

Explore

Pipeline

Devoted to New Discoveries

Our scientists are advancing a pipeline of specialty medicines with a focus on cancer, immune-mediated conditions, neurodegenerative diseases and more.

Explore opens in a new window

20

products with potential for new drug or indication approvals by the end of 2020

15

programs in Phase III under way

~16k

employees who work in STEM

1 of 3
2 of 3
3 of 3

Discovering and developing therapies that have the potential to transform the standard of care for people battling serious and often life-threatening illnesses is our core mission.

Michael Severino, M.D, Executive Vice President, R&D and Chief Scientific Officer

Our Products

A Portfolio of Medicines

We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe.

Explore opens in a new window